Web6 feb. 2024 · Waldenstrom’s macroglobulinemia (WM) is an indolent B-cell non-Hodgkin lymphoma (NHL) representing 1-2% of all NHLs characterized by lymphoplasmacytic histology in the bone marrow, with monoclonal IgM [1, 2].WM was first described in 1944 as having myeloma-like features, with proliferation of B cells causing increased serum IgM … WebLymphoplasmacytic lymphoma (LPL) is a rare, slowgrowing tumour of the lymphoid tissue that is usually associated with a serum IgM paraprotein, known as Waldenström macroglobulinemia (WM) [1].
淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(LPL/WM)-最新版NCCN指 …
Web23 mai 2024 · Lymphoplasmacytic lymphoma, or Waldenstrom macroglobulinemia, is a low-grade B cell lymphoproliferative neoplasm … WebG. Gremmel is an academic researcher. The author has contributed to research in topic(s): Lymphoblastic lymphoma & Lymphoma. The author has an hindex of 1, co-authored 1 publication(s) receiving 33 citation(s). netheravon terrace
Current and Emerging Treatments for Waldenström …
Web13 sept. 2024 · Laryngeal lymphoma is a rare presentation of lymphoma, with less than 100 cases reported in the literature to date [1]. Specifically, laryngeal … WebWaldenström macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma. The primary goal of therapy is to reduce symptoms related to direct infiltration of the bone marrow and decrease monoclonal IgM-associated complications. Active agents in the management of WM can be broadly classified as rituximab-alkylator combination … Web8 oct. 2024 · Lymphoplasmacytic lymphoma (LPL) is a rare, slow-growing tumour of the lymphoid tissue that is usually associated with a serum IgM paraprotein, known as Waldenström macroglobulinemia (WM) [].Rarely, a few cases present with IgG, IgA or without a monoclonal protein [].It is a rare subtype of non-Hodgkin lymphoma. itweae vitronics